Verona Pharma earnings were -$81.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest VRNA earnings report on Jun 30, 2025 announced Q2 2025 earnings of $11.9M, down 173% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VRNA reported annual earnings of -$173.4M, with 219% growth. The next VRNA earnings date is Nov 11, 2025.
On VRNA's earnings call on Invalid Date, Verona Pharma (NASDAQ: VRNA) reported Q2 2025 earnings per share (EPS) of $0.16, up 118.18% year over year. Total VRNA earnings for the quarter were $11.92 million. In the same quarter last year, Verona Pharma's earnings per share (EPS) was -$0.88.
The next VRNA earnings call is Invalid Date. Add VRNA to your watchlist to be reminded of Verona Pharma's next earnings date.
Is Verona Pharma profitable or losing money?
As of the last Verona Pharma earnings report, Verona Pharma is currently losing money. Verona Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$81.19 million, a 35.28% decrease year over year.
What was VRNA's earnings growth in the past year?
As of Verona Pharma's earnings date in Invalid Date, Verona Pharma's earnings has grown year over year. VRNA earnings in the past year totalled -$81.19 million.
What are Verona Pharma's earnings expectations?
The current EPS estimate for Verona Pharma's earnings report in Invalid Date is $0.18.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.